SCHEMBL6404844

SCHEMBL6404844

C[C@@H](NC(=O)C1(c2ccc(Cl)cc2)CC1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
TP53 P04637 1/20 0.50
HTT P42858 1/20 0.50
GPR139 Q6DWJ6 1/20 0.49
HDAC4 P56524 1/20 0.49
GRIN2B Q13224 1/20 0.47
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HSD11B1 P28845 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
THRB P10828 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PRCP P42785 1/20 0.45
HPGD P15428 1/20 0.45
AVPR1A P37288 2/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410915 1.00 ALDH1A1 (0.62) ALDH1A1TP53HTTGPR139HDAC4
SCHEMBL7912225 0.86 ALDH1A1 (0.53) ALDH1A1TP53HTTGPR139HDAC4
SCHEMBL6413085 0.85 CYP2D6 (0.50) ALDH1A1HDAC4HSD11B1MEN1KMT2A
SCHEMBL6405636 0.85 CYP2D6 (0.50) ALDH1A1HDAC4HSD11B1MEN1KMT2A
SCHEMBL6406223 0.85 CYP2D6 (0.50) ALDH1A1HDAC4HSD11B1MEN1KMT2A
SCHEMBL6413090 0.85 CYP2D6 (0.50) ALDH1A1HDAC4HSD11B1MEN1KMT2A
SCHEMBL14491529 0.83 HDAC4 (0.60) ALDH1A1TP53HTTHDAC4LMNA
SCHEMBL5358777 0.83 HDAC4 (0.60) ALDH1A1TP53HTTHDAC4LMNA
SCHEMBL14491528 0.83 HDAC4 (0.60) ALDH1A1TP53HTTHDAC4LMNA
SCHEMBL4971403 0.83 HDAC4 (0.46) ALDH1A1HTTHDAC4LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288338-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2005-12-29 US claimed
US-20050288338-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288338-A1 Amido compounds and their use as pharmaceuticals HSD11B1, CYP11B1, HSD11B2 ALDH1A1 345/4885TP53 4768/4885HTT 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.